Healthtech firm Flatiron Well being is collaborating with NRG Oncology, a scientific analysis consortium within the Nationwide Most cancers Institute’s Nationwide Medical Trials Community with greater than 1,300 worldwide analysis websites, to deploy Flatiron Medical Pipe in a multicenter NRG scientific trial.
Flatiron Medical Pipe is an digital well being document (EHR) to digital information seize (EDC) connector that goals to enhance effectivity and cut back effort and time of scientific examine information entry.
The intention of the collaboration is to broaden Flatiron Medical Pipe use instances to incorporate NCTN-sponsored research by making use of Flatiron’s EHR-to-EDC expertise to cut back the burden on NRG scientific trial web site groups, streamline information administration and speed up examine timelines.
NRG and Flatiron will conduct a correlative examine to evaluate the effectivity of Flatiron Medical Pipe use in comparison with conventional information entry strategies.
“Collaborating with NRG Oncology, a number one analysis consortium throughout the Nationwide Medical Trials Community, is an unimaginable alternative to create a brand new trial expertise, unlocking greater information high quality and extra environment friendly information acquisition with Flatiron Medical Pipe,” Alex Deyle, normal supervisor of scientific analysis at Flatiron Well being, stated in a press release.
“By placing our cutting-edge expertise within the arms of extra analysis groups, Flatiron and NRG will improve our ongoing efforts to enhance effectivity and cut back effort and time of examine information seize, in the end accelerating proof era and enhancements in take care of individuals with most cancers.”
Healthcare AI platform Notable entered right into a multiyear partnership with CityMD, an pressing care supplier in New York and New Jersey.
By way of the partnership, CityMD will leverage Notable’s AI and automation expertise at 180-plus websites with the intention of bettering affected person entry, driving operational effectivity and decreasing the executive burden related to walk-in care.
The alliance will see Notable’s AI platform and clever brokers driving automation throughout a number of use instances, together with pressing care scheduling, messaging, affected person registration and consumption and funds.
“Pressing care is a essential gateway to the healthcare system for hundreds of thousands, but sufferers typically encounter pointless delays and boundaries to well timed care,” Pranay Kapadia, CEO of Notable, stated in a press release.
“By bringing Notable’s AI-powered automation to CityMD, we’re addressing these challenges head-on. Our expertise streamlines each appointment, registration, and follow-up, making certain that healthcare groups can function extra effectively regardless of staffing shortages.”
Bamboo Well being, a real-time care intelligence firm, introduced a partnership with the state of Ohio to bolster its prescription drug monitoring system, often known as the Ohio Automated Rx Reporting System (OARRS).
The state expects to perform this by including a characteristic instantly of their present workflows that alerts healthcare suppliers if a affected person has a previous historical past of drug overdoses.
OD Insights is the latest addition to Bamboo Well being’s Prescription Drug Monitoring Program suite and is geared toward bettering care coordination so emergency departments can steer high-risk sufferers to essentially the most related therapy choices, together with entry to remedy for opioid use dysfunction and different instruments to forestall deadly overdoses.
Based on the corporate, by integrating seamlessly into OARRS, OD Insights provides well timed, pertinent information to help scientific decision-making whereas sustaining the identical protections afforded prescription information.
Moreover, it permits suppliers to carefully view a affected person’s managed substance use historical past on the level of care to help knowledgeable prescribing practices as a part of a multidimensional response to the continued opioid epidemic.
“The Ohio Board of Pharmacy continues to be on the forefront of leveraging expertise to handle the opioid epidemic,” Ross Armstrong, chief business officer at Bamboo Well being, stated in a press release.
“We’re honored to associate with Ohio to implement OD Insights and consider this initiative will function a mannequin for different states seeking to develop entry to hurt discount and therapy.”
